Sun Pharma Advanced Research Company informs about issuance of duplicate share certificate

05 Dec 2022 Evaluate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed details of request for issue of duplicate share certificate reported by shareholder of the Company, received from its Registrar and Transfer Agent, Link Intime India on December 05, 2022. Accordingly, in compliance with the SEBI Circular No. SEBI/HO/MIRSD /MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, a Letter of Confirmation in lieu of the original share certificate will be issued to the respective shareholders of the Company.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

141.85 2.35 (1.68%)
04-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 472.05
Indegene 479.95
CMS Info Systems 316.90
Sagility 48.11
Smartworks Coworking 459.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×